Degeneration of axons is a prominent cause of morbidity spanning several neurological conditions including neurotrauma, stroke, autoimmune, and neurodegenerative diseases. Unlike the peripheral nervous system (PNS), central nervous system (CNS) axons have a limited capacity to regenerate once injured due to both intrinsic and extrinsic barriers (i.e., inhibitory molecules to axonal growth produced during scar formation and liberated during myelin degeneration)1-7. Although several of these barriers have been extensively explored, therapeutic interventions aimed to prevent CNS axonal degeneration, promote robust axonal regeneration, and restore functional connectively, remain limited.
Axons once separated from their soma undergo a stereotypical process of degeneration known as Wallerian degeneration that is characterized by axonal swelling, spheroid formation and eventual fragmentation (reviewed in 8). In contrast, the proximal stump that remains in continuity with the soma of a transected peripheral axon, forms a swelling at its end, dies back to the nearest node of Ranvier, and can then initiate growth cone formation, a vital prerequisite necessary for subsequent axonal regeneration9-11. In contrast, the proximal axonal endings of many central axons form characteristic “endbulbs” or retraction bulbs, fail to form growth cones, and instead retract away from the injury site where they remain for months after injury12-15. In addition to the primary axonal injury, additional axonal damage/loss may also occur to axons that were largely spared from the initial injury. This delayed axonal loss of initially spared axons is referred to as secondary axonal degeneration. This inherent response of CNS axons to injury renders functional axonal regeneration an even more difficult goal to achieve in the brain and spinal cord.
Although hallmarks of axonal injury (e.g., spheroid formation, retraction bulbs) have been well characterized from post-mortem tissue and experimental models of axonal degeneration, elucidation of the molecular mechanisms underlying these dynamic processes has been restricted. Most of these studies relied on static endpoint observations that inherently failed to capture individual axonal responses over time. Though exogenously applied axonal tracers have been useful to elucidate axonal responses from static sections and during live imaging, the availability of genetically encoded axonal markers has greatly improved our ability to visualize axons in real-time using fluorescence microscopy. Indeed, a seminal report from Kerschensteiner and colleagues first provided direct evidence of axonal degeneration and regeneration in vivo using Thy1-GFP-S mice that encode green fluorescent protein in subsets of neurons that send their projections in the dorsal columns of the spinal cord16. Live imaging approaches using two photon laser scanning microscopy (TPLSM) and genetic fluorescent protein labeling of cells of interest continues to provide direct evidence and mechanistic insight into many diverse dynamic processes such as axonal degeneration, Ca2+ signaling, axonal regeneration, astrocyte physiology, microglial physiology, and response to injury17-25.
In contrast to axons, very little is known of myelin responses to injury in real-time. Myelin is a vital component of white matter produced and maintained by oligodendrocytes in the CNS and Schwann cells in the PNS. Myelin insulates 99% of the surface of axons and by doing so provides a high-resistance, low-capacitance protective covering that supports rapid and efficient saltatory impulse propagation, recently reviewed by Buttermore et al.26. To capture the dynamic response of myelin to injury we use the solvatochromic, lipophilic fluorescent dye Nile Red27. The solvatochromic properties of this vital stain allow spectral shifts of its emission spectrum that is dependent on the physico-chemical environment28,29. These properties are useful to gain insight into mechanisms of axomyelinic injury and can be visualized using appropriately selected dichroics and emission filters or resolved using spectral microscopy27. For example, Nile Red’s emission spectrum is blue-shifted in less polar, lipid-rich environments such as those found in adipocytes and normal CNS myelin (peak emission ~ 580-590 nm)27. In contrast, this vital dye’s emission spectrum peaks at ~ 625 nm in endbulbs formed as axons undergo axonal dieback27. Although the precise mechanisms underlying these spectral shifts specifically in endbulbs versus normal myelin remain unclear, such spectral changes may reveal underlying alterations in protein accumulation or disorganization leading to exposure of hydrophobic binding sites 27.
While in vivo imaging is the ultimate metric for observing spinal cord axonal injury dynamics in their native environment, it is technically challenging and requires substantial surgical expertise, and often repeat surgeries to expose the dorsal column that may introduce experimental artifacts (e.g., inflammation and scar formation). In addition, costly equipment is often needed to allow suspension and positioning of an intact animal under the microscope objective lens. The animals need to be carefully monitored as well to ensure they remain warm, to ensure fluids are replenished, and to ensure there are no signs of hypoxia due to prolonged anesthetized imaging sessions. The latter is extremely important as axons and myelin absolutely require constant perfusion and adequate oxygen levels to remain viable. However, this is often not reported or monitored in most in vivo studies to date. In addition, movement artifacts due to heart rate and breathing (isoflurane anesthetized adult mouse: ~ 300-450 beats per min (BPM) is optimal to maintain 97-98% oxygen saturation (normal rate ~ 632 BPM) and ~ 55-65 breaths per min (normal rate is ~ 163 breaths per min), respectively))30 encountered during in vivo spinal cord imaging make differentiating primary and secondary axonal injury responses using high resolution fluorescence microscopy challenging as even the fastest laser scans unavoidably are subject to these movement artifacts. Advances in ultrafast resonant scanners combined with an implantable rigid vertebral framed window may allow imaging of the murine spinal cord in awake animals, but faster scan times inevitably reduce the signal to noise ratio degrading image quality. Further improvements in spinal cord imaging techniques as currently used for brain imaging may overcome many of these obstacles and limit potential confounds introduced by inadequate tissue perfusion, e.g., 31-33.
Much of what is known about white matter physiology and mechanisms of white matter injury has been determined using in vitro or ex vivo preparations of white matter from optic nerve, peripheral nerve, and strips of spinal cord white matter34-41. These preparations continue to advance our knowledge of white matter injury mechanisms as they allow controlled changes in environmental factors, controlled application of drugs and reagents, functional assessments using electrophysiology, and direct fluorescence microscopy observations of axons and myelin in living tissue. Yet, some previous approaches to observe axons from spinal cord dorsal column strips or ventral white matter strips unavoidably injure surface axons during the removal stage that may influence the response of closely opposed axons. To capitalize on the experimental manipulations above and avoid damage to the very fibers under investigation, we use an ex vivo cervical spinal cord model as it prevents direct contact of the dorsal aspect of the cord. Thus, the architecture of the pia mater and adjacent superficial dorsal column axons remain viable and unperturbed during isolation.
Here we describe a relatively simple approach that allows direct visualization of central myelinated axons as they dynamically respond to a focal injury in real-time up to 8 - 10+ hr after injury. The laser-induced spinal cord injury (LiSCI) model allows differentiation between primary and secondary axonal injury mechanisms as the primary lesion (ablation site) remains spatially constrained over time. The open-bath imaging chamber is accessible to therapeutic intervention, reagent delivery, and environmental manipulations. Putative axomyelinic protective agents can be quickly assessed in real-time by direct observations versus lengthy and costly experiments involving tissue processing, sectioning, immunostaining, image capture, and analysis and therefore provides a useful surrogate model to assess acute responses and protective manipulations before testing the experimental agents in live animals.